Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Michael Friis

Head of Equities

Michael Friis portrait

Coverage

HydractAudientesRealfictionShape RoboticsScape TechnologiesGreenMobilityCurasightOrderYOYOPenneoPhotocatOdicoAgillicBawat Water TechnologiesImperoMapsPeopleNNITNordic SolarScandinavian Medical SolutionsWindowMaster InternationalGomSpace GroupCABA CapitalAscelia PharmaEmbla MedicalBioPortoGubraExpreS2ion Biotech Holding

Latest content

ShowingAll content types

GomSpace – 7.6 MEUR contract with VirtuaLabs for RF monitoring satellite constellation

Analyst Comment 04.03.2026 klo 15.13 by Michael Friis
GomSpace Group

Curasight (One-pager): Pivotal data readouts ahead in 2026

Research 03.03.2026 klo 15.25 by Michael Friis
Curasight

MPC Energy Solutions: Recording of preliminary 2025 result presentation

Analyst Comment 27.02.2026 klo 16.13 by Michael Friis
MPC Energy Solutions

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account

Agillic (One-pager) - Strategic reset bearing fruit as earnings momentum continues into 2026

Research 26.02.2026 klo 16.15 by Michael Friis, Victor Skriver
Agillic

Gubra:  CTA submitted for first-in-human study of lead asset GUB-UCN2

Analyst Comment 26.02.2026 klo 09.06 by Michael Friis
Gubra

ExpreS2ion Biotech (One-pager): Progress continues on both pipeline and partner driven programs

Research 25.02.2026 klo 15.19 by Philip Coombes, Michael Friis
ExpreS2ion Biotech Holding

GomSpace (One-pager): Scaling to capture a fast-growing market opportunity

Research 25.02.2026 klo 09.00 by Michael Friis, Victor Skriver
GomSpace Group

Rovsing (One-pager): Near-term headwinds, growing tender activity, and a new ESA cycle ahead

Research 19.02.2026 klo 16.45 by Michael Friis, Victor Skriver
Rovsing

GomSpace: Presentation of 2025 Full-Year results (Recording)

Analyst Comment 19.02.2026 klo 14.55 by Michael Friis
GomSpace Group

ExpreS2ion: Presentation of Q4 2025 report (Recording)

Analyst Comment 19.02.2026 klo 14.42 by Michael Friis
ExpreS2ion Biotech Holding
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.